(Q46886510)

English

Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels.

scientific article published on 21 November 2007

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

18032571

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032571%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

title

Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

18032571

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032571%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

0 references

1

1 reference

stated in

Europe PubMed Central

PubMed ID

18032571

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032571%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

author name string

Michael H Baumann

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

18032571

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032571%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

Richard B Rothman

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

18032571

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032571%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

language of work or name

English

0 references

publication date

21 November 2007

1 reference

stated in

Europe PubMed Central

PubMed ID

18032571

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032571%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

published in

Journal of Pharmacology and Experimental Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed ID

18032571

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032571%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

volume

324

1 reference

stated in

Europe PubMed Central

PubMed ID

18032571

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032571%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed ID

18032571

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032571%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

page(s)

791-797

1 reference

stated in

Europe PubMed Central

PubMed ID

18032571

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032571%20AND%20SRC:MED&resulttype=core&format=json

(Q46886510)

Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)